BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

NeoCart: Phase II data

An open-label, U.S. Phase II trial in 30 patients showed that NeoCart met the primary endpoint of significantly improving knee and general health outcomes scores as measured by IKDC, KOOS, VAS and short form 36 at 12 months vs. microfracture surgery (p<0.025 for all)....

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >